Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

571.00p
   
  • Change Today:
      12.00p
  • 52 Week High: 1,545.00p
  • 52 Week Low: 130.00p
  • Currency: UK Pounds
  • Shares Issued: 5.92m
  • Volume: 32,993
  • Market Cap: £33.79m
  • RiskGrade: 340

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £1,071,921
Vladislav Sandler Ph.D. 103,862 £593,052
Peter Redmond 13,991 £79,889

Major Shareholders

Notifier** Holding Value*
David John Smith 399,478 £2,281,019
Alexis Sandler 187,726 £1,071,916
Dr Vladislav Sandler 103,862 £593,052
Optiva Securities Limited 70,329 £401,579
Flascherberg Capital Anstalt 69,991 £399,649
Craig Auringer 59,593 £340,276
HSBC Client Holdings Nominee (UK) Limited 45,160 £257,864
Ron Valk 42,828 £244,548
Samantha Bauer 42,706 £243,851
Plum Capital 29,232 £166,915
43 North LLC 28,429 £162,330
Abdelatif LACHAB 6,500 £37,115
Wayne Gibson 6,500 £37,115

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 571.00p
Change Today 12.00p
% Change 2.15 %
52 Week High 1,545.00p
52 Week Low 130.00p
Volume 32,993
Shares Issued 5.92m
Market Cap £33.79m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47% below the market average47% below the market average47% below the market average47% below the market average47% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average
Price Trend
91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average
90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 10-Dec-2025

Time Volume / Share Price
16:27 513 @ 580.00p
15:59 20 @ 610.00p
15:53 3 @ 616.00p
15:43 81 @ 617.10p
15:37 162 @ 610.50p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page